Works about MYELOID leukemia

Results: 5000
    1

    Study of Expression of MST3 in Myeloid Leukaemia.

    Published in:
    Medical Sciences, 2025, v. 13, n. 2, p. 33, doi. 10.3390/medsci13020033
    By:
    • Arthi, Boro;
    • Sujatha, Krishnaswamy;
    • Gopal, Sridhar;
    • Balamuralikrishnan, Balasubramanian;
    • Arun, Meyyazhagan;
    • Manikantan, Pappuswamy;
    • Sampathkumar, Palanisamy;
    • Anand, Arumugam Vijaya
    Publication type:
    Article
    2
    3

    Genetic Variants in Oxidative Stress-Related Genes and Their Impact on Prognosis and Treatment Response in Chronic Myeloid Leukemia Patients.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 12, p. 5682, doi. 10.3390/ijms26125682
    By:
    • Alves, Raquel;
    • Ventura, Filipa;
    • Jorge, Joana;
    • Marques, Gilberto;
    • Coucelo, Margarida;
    • Diamond, Joana;
    • Oliveiros, Bárbara;
    • Pereira, Amélia;
    • Freitas-Tavares, Paulo;
    • Almeida, António M.;
    • Gonçalves, Ana Cristina;
    • Sarmento-Ribeiro, Ana Bela
    Publication type:
    Article
    4
    5
    6

    Chronic myelogenous leukemia.

    Published in:
    Postgraduate Medicine, 1999, v. 106, n. 3, p. 149
    By:
    • Hill, John M.;
    • Meehan, Kenneth R.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Granulocytic sarcoma in children.

    Published in:
    Neuroradiology, 2004, v. 46, n. 5, p. 374
    By:
    • Porto, L.;
    • Kieslich, M.;
    • Schwabe, D.;
    • Zanella, F.E.;
    • Lanfermann, H.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Research highlights.

    Published in:
    Nature Immunology, 2006, v. 7, n. 7, p. 707, doi. 10.1038/ni0706-707
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. e1070, doi. 10.1634/theoncologist.2019-0976
    By:
    • Tzogani, Kyriaki;
    • Røshol, Hilde;
    • Olsen, Helga Haugom;
    • Aas, Ida B.;
    • Dalhus, Marianne Løiten;
    • Håkonsen, Gro Dahlseng;
    • Nilssen, Laila Sortvik;
    • Lindberg, Vibeke;
    • Økvist, Mats;
    • Bolstad, Bjørg;
    • Rogovska, Irēna;
    • Karpova, Natalja;
    • Enzmann, Harald;
    • Gisselbrecht, Christian;
    • Pignatti, Francesco
    Publication type:
    Article
    34
    35
    36
    37
    38

    Over-Expressed GATA-1 S , the Short Isoform of the Hematopoietic Transcriptional Factor GATA-1, Inhibits Ferroptosis in K562 Myeloid Leukemia Cells by Preventing Lipid Peroxidation.

    Published in:
    Antioxidants, 2023, v. 12, n. 3, p. 537, doi. 10.3390/antiox12030537
    By:
    • Trombetti, Silvia;
    • Iaccarino, Nunzia;
    • Riccio, Patrizia;
    • Sessa, Raffaele;
    • Catapano, Rosa;
    • Salvatore, Marcella;
    • Luka, Stelina;
    • de Nicola, Sergio;
    • Izzo, Paola;
    • Roperto, Sante;
    • Maddalena, Pasqualino;
    • Randazzo, Antonio;
    • Grosso, Michela
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45

    Prediction of infectious events by the high-sensitivity C-reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma.

    Published in:
    Transplant Infectious Disease, 2013, v. 15, n. 4, p. E169, doi. 10.1111/tid.12102
    By:
    • Sato, M.;
    • Nakasone, H.;
    • Wada, H.;
    • Yamasaki, R.;
    • Ishihara, Y.;
    • Sakamoto, K.;
    • Kawamura, K.;
    • Ashizawa, M.;
    • Machishima, T.;
    • Terasako, K.;
    • Kimura, S.‐I.;
    • Kikuchi, M.;
    • Tanihara, A.;
    • Yamazaki, R.;
    • Tanaka, Y.;
    • Kanda, J.;
    • Kako, S.;
    • Nishida, J.;
    • Kanda, Y.
    Publication type:
    Article
    46
    47
    48
    49
    50